Cargando…

Cancer Stem Cell Chemotherapeutics Assay for Prospective Treatment of Recurrent Glioblastoma and Progressive Anaplastic Glioma: A Single-Institution Case Series()

BACKGROUND: Chemotherapy-resistant cancer stem cells (CSC) may lead to tumor recurrence in glioblastoma (GBM). The poor prognosis of this disease emphasizes the critical need for developing a treatment stratification system to improve outcomes through personalized medicine. METHODS: We present a cas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ranjan, Tulika, Howard, Candace M., Yu, Alexander, Xu, Linda, Aziz, Khaled, Jho, David, Leonardo, Jodi, Hameed, Muhammad A., Karlovits, Stephen M., Wegner, Rodney E., Fuhrer, Russell, Lirette, Seth T., Denning, Krista L., Valluri, Jagan, Claudio, Pier Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2020
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078520/ https://www.ncbi.nlm.nih.gov/pubmed/32197147 http://dx.doi.org/10.1016/j.tranon.2020.100755

Ejemplares similares

Treatment of unmethylated MGMT-promoter recurrent glioblastoma with cancer stem cell assay-guided chemotherapy and the impact on patients’ healthcare costs
por: Ranjan, Tulika, et al.
Publicado: (2023)

Clinical relevance of cancer stem cell chemotherapeutic assay for recurrent ovarian cancer()
por: Howard, Candace M., et al.
Publicado: (2020)

National trends in radiation dose escalation for glioblastoma
por: Wegner, Rodney E., et al.
Publicado: (2019)

Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial
por: Ranjan, Tulika, et al.
Publicado: (2023)

Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients
por: Howard, Candace M., et al.
Publicado: (2017)

Cancer Stem Cell Assay for the Treatment of Platinum-Resistant Recurrent Ovarian Cancer
por: Howard, Candace M, et al.
Publicado: (2021)

SYST-01 MULTI-INSTITUTIONAL RANDOMIZED TRIAL COMPARING CANCER STEM CELL-TARGETED VS PHYSICIAN-CHOICE TREATMENTS IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS (NCT03632135)
por: Sengupta, Soma, et al.
Publicado: (2022)

Rapid Selection and Proliferation of CD133(+) Cells from Cancer Cell Lines: Chemotherapeutic Implications
por: Kelly, Sarah E., et al.
Publicado: (2010)

Minimally Manipulative Method for the Expansion of Human Bone Marrow Mesenchymal Stem Cells to Treat Osseous Defects
por: Lawrence, Logan M., et al.
Publicado: (2019)

Linear Accelerator-Based Stereotactic Radiotherapy for Low-Grade Meningiomas: Improved Local Control With Hypofractionation
por: Wegner, Rodney E, et al.
Publicado: (2019)

COVD-01. ADAPTATION OF A GAMMA KNIFE ICON STEREOTACTIC RADIOSURGERY PROGRAM IN THE FACE OF A GLOBAL PANDEMIC
por: Wegner, Rodney, et al.
Publicado: (2020)

Single Fraction Frameless Stereotactic Radiosurgery on the Gamma Knife Icon for Patients With Brain Metastases: Time to Abandon the Frame?
por: Wegner, Rodney E., et al.
Publicado: (2021)

Trends in the use of radiation for meningioma across the United States
por: Matani, Hirsch, et al.
Publicado: (2022)

The feasibility of MRI texture analysis in distinguishing glioblastoma, anaplastic astrocytoma and anaplastic oligodendroglioma
por: Teng, Yuen, et al.
Publicado: (2022)

Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma
por: Annovazzi, Laura, et al.
Publicado: (2017)

Anaplastic ependymoma simulating glioblastoma in the cerebrum of an adult
por: Shintaku, Masayuki, et al.
Publicado: (2011)

Update on Chemotherapeutic Approaches and Management of Bevacizumab Usage for Glioblastoma
por: Funakoshi, Yusuke, et al.
Publicado: (2020)

A Comparison of Single Fraction and Multi Fraction Radiosurgery on the Gamma Knife ICON: A Single Institution Review
por: Loftus, Joseph P., et al.
Publicado: (2022)

Linear accelerator-based radiosurgery and hypofractionated stereotactic radiotherapy for brain metastasis secondary to gynecologic malignancies: A single institution series examining outcomes of a rare entity
por: Gigliotti, Michael J., et al.
Publicado: (2018)

Flavonoids Synergistically Enhance the Anti-Glioblastoma Effects of Chemotherapeutic Drugs
por: Zhai, Kevin, et al.
Publicado: (2021)

Carboplatin Plus Vincristine as an Alternative Chemotherapeutic Scheme in Patients With Glioblastoma
por: Sangrador-Deitos, Marcos V, et al.
Publicado: (2022)

Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma
por: Kessler, Tobias, et al.
Publicado: (2015)

Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma
por: MAYER, ARNULF, et al.
Publicado: (2012)

Glioblastoma and Anaplastic Astrocytoma: Differentiation Using MRI Texture Analysis
por: Tian, Zerong, et al.
Publicado: (2019)

T2 mapping of the peritumoral infiltration zone of glioblastoma and anaplastic astrocytoma
por: Auer, Timo Alexander, et al.
Publicado: (2021)

Chemo-Predictive Assay for Targeting Cancer Stem-Like Cells in Patients Affected by Brain Tumors
por: Mathis, Sarah E., et al.
Publicado: (2014)

Predictors of Treatment Interruption During Frameless Gamma Knife Icon Stereotactic Radiosurgery
por: Wegner, Rodney E., et al.
Publicado: (2020)

Odds of death after glioblastoma diagnosis in the United States by chemotherapeutic era
por: Wachtel, Mitchell S, et al.
Publicado: (2014)

A 16-Gene Signature Distinguishes Anaplastic Astrocytoma from Glioblastoma
por: Rao, Soumya Alige Mahabala, et al.
Publicado: (2014)

Safety and efficacy of concomitant chemotherapeutic wafers and iodine-125 seeds for recurrent glioblastoma
por: Ko, Andrew L., et al.
Publicado: (2012)

Graphene Quantum Dots’ Surface Chemistry Modulates the Sensitivity of Glioblastoma Cells to Chemotherapeutics
por: Perini, Giordano, et al.
Publicado: (2020)

A Novel Blood-Brain Barrier-Permeable Chemotherapeutic Agent for the Treatment of Glioblastoma
por: Ozawa, Tomoko, et al.
Publicado: (2021)

Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma
por: Maier, Julian P., et al.
Publicado: (2021)

The Positive Impact of a Chemotherapeutic Approach on Relapse Ependymoma or WHO Grade III Anaplastic Ependymoma: Report of a Rare Case
por: Meghe, Abhyuday, et al.
Publicado: (2022)

Co-inhibition of glutaminolysis and one-carbon metabolism promotes ROS accumulation leading to enhancement of chemotherapeutic efficacy in anaplastic thyroid cancer
por: Hwang, Yeseong, et al.
Publicado: (2023)

Multiparametric Magnetic Resonance Imaging in the Assessment of Primary Brain Tumors Through Radiomic Features: A Metric for Guided Radiation Treatment Planning
por: Florez, Edward, et al.
Publicado: (2018)

The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas
por: Christians, Arne, et al.
Publicado: (2019)

Hypofractionated image guided radiation therapy followed by prostate seed implant boost for men with newly diagnosed intermediate and high risk adenocarcinoma of the prostate: Preliminary results of a phase 2 prospective study
por: Gresswell, Steven, et al.
Publicado: (2016)

Utilization of Stereotactic Ablative Body Radiation Therapy for Intact Renal Cell Carcinoma: Trends in Treatment and Predictors of Outcome
por: Wegner, Rodney E., et al.
Publicado: (2019)

The DNA damage/repair cascade in glioblastoma cell lines after chemotherapeutic agent treatment
por: ANNOVAZZI, LAURA, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u6hsen2301a3dp47fhe43m9uvs